Top

12-03-2016 | Staging | Article

Renal cell carcinoma: staging and surveillance

Journal: Abdominal Radiology

Author: N. Reed Dunnick

Abstract

Renal cell carcinoma is a common malignancy with many histologic subtypes. Appropriate treatment depends not only upon the specific subtype but also the size of the tumor and extent of spread at time of presentation. Approximately 5% of RCCs are part of a hereditary syndrome which must also be considered in the therapeutic decisions. Although some RCCs are detected with ultrasound, CT or MR is required for staging. CT is used most commonly as it is most readily available and relatively less expensive than MR imaging. The TNM classification of the American Joint Committee on Cancer has largely replaced the Robson classification. Early detection, accurate staging, and improved treatment options have resulted in improved 5-year survival of patients with renal carcinoma.

Ng C, Wood CG, Silverman P, et al. (2008) Renal Cell Carcinoma: Diagnosis, Staging, and Surveillance. Am J Radiol 191(4):1220–1232

Prasad SR, Humphrey PA, Catena FR, et al. (2006) Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. RadioGraphics 26:1795–1806CrossRefPubMed

Shanbhogue K, Alampady V, Raghunandan P, et al. (2012) Rare (<1%) histological subtypes of renal cell carcinoma: an update. Abdom Imaging 37:861–872CrossRefPubMed

Shinagare A, Krajewski Katherine M, Jagannathan JP, Ramaiya N (2012) Genitourinary imaging: part 2, role of imaging in medical management of advanced renal cell carcinoma. Am J Radiol 199(5):W554–W564

Northrup EB, Jokerst CE, Grubb RL, et al. (2012) Hereditary renal tumor syndromes: imaging findings and management strategies. Am J Radiol 199:1294–1304

Escudier B, Porta C, Schmidinger M, et al. (2012) Renal cell carcinoma: ESMO clinical practice guidelines for diagnosis. Treatment and follow-up. Ann Oncol 23(7):vii65–vii71PubMed

Kane C, Mallin K, Ritchey J, Cooperberg M, Carroll P (2008) Renal cell cancer stage migration: analysis of the national cancer data base. Am Cancer Soc 113(1):78–83

Howlader N, Noone AM, Krapcho M, Garshell J, Miller D, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, Mariotto A, Lewis DR, Chen HS, Feuer EJ, Cronin KA, (eds). ERRT cancer statistics review, 1975–2012. Bethesda, MD: National Cancer Institute. http://seer.cancer.gov/csr/1975_2012/ (http://seer.cancer.gov/csr/), based on November 2014 SEER data submission, posted to the SEER website, April 2015

Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301PubMed

10.

Brufau BP, Cergueda CS, Villalba LB, et al. (2013) Metastatic renal cell carcinoma: radiologic findings and assessment of response to targeted antiangiogenic therapy by using multidetector CT. Radiographics 33(6):1691–1715CrossRefPubMed

11.

Bianchi M, Sun M, Jeldres C, et al. (2012) Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol 23(4):973–980CrossRefPubMed

12.

Vikram R, Ng CS, Tamboli P, et al. (2009) Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. RadioGraphics 29:741–754CrossRefPubMed

13.

Davenport M, Neville A, Ellis J, et al. (2011) Diagnosis of renal angiomyolipoma with hounsfield unit thresholds: effect of size of region of interest and nephrographic phase imaging. Radiology 260(1):158–165CrossRefPubMed

14.

Guinana PD, Vogelzang NJ, Fremgen AM, et al. (1995) Renal cell carcinoma: tumor size, stage and survival. J Urol 153:901–903CrossRef

15.

Tsui KH, Shvarts O, Smith RO, Figlin JB (2000) Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol 163:1090–1095CrossRefPubMed

16.

Johnson CD, Dunnick NR, Cohan RH, Illescas FF (1987) Renal adenocarcinoma: CT staging of 100 tumors. AJR 148:59–63CrossRefPubMed

17.

Ergen FB, Hussain H, Caoili EM, et al. (2004) MRI for preoperative staging of renal cell carcinoma using the 1997 TNM classification: comparison with surgical and pathologic staging. Am J Radiol 182(1):217–225

18.

Karlo C, Donati OF, Marigliano C, et al. (2013) Role of CT in the assessment of muscular venous branch invasion in patients with renal cell carcinoma. Am J Radiol 201(4):847–852

19.

Hatcher PA, Anderson EE, Paulson DF, Carson CC, Robertson JE (1991) Surgical management and prognosis of renal cell carcinoma invading the vena cava. J Urol 145:20–24PubMed

20.

Russo P (2000) Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol 27:160–176PubMed

21.

Prasad SR, Humphrey PA, Catena JR, et al. (2006) Common and uncommon histological subtype of renal cell carcinoma: imaging spectrum with pathologic correlation. RadioGraphics 26:1795–1806CrossRefPubMed

22.

Patel U, Sokhi H (2012) Imaging in the follow-up of renal cell carcinoma. Am J Radiol 198(6):1266–1276

23.

Sivaramakrishna B, Gupta NP, Wadhwa P, et al. (2005) Pattern of metastases in renal cell carcinoma: a single institution study. Indian J Cancer 42:173–177PubMed

24.

Scatarage JC, Sheth S, Corl FM, Fishman EK (2001) Patterns of recurrence in renal cell carcinoma: manifestations on helical CT. Am J Radiol 177:653–658

25.

Dunnick NR, Wixson D, Doppman JL, Bokinski G, Javadpour N (1979) Metastatic renal cell carcinoma to the remaining kidney 14 years after nephrectomy—report of 2 cases. Cardiovasc Radiol 2:127–130CrossRefPubMed

26.

Miyao N, Naito S, Ozono S, et al. (2011) Late recurrence of renal cell carcinoma: retrospective and collaborative study of the Japanese society of renal cancer. Urology 77:379–384CrossRefPubMed

27.

Klatte T, Lam JS, Shuch B, Belldegrum AS, Pantuck AJ (2008) Surveillance for renal cell carcinoma: why and how? When and how often? Urol Oncol 26:550–554CrossRefPubMed

28.

Matin SF, Ahrar K, Cadeddu JA, et al. (2006) Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176:1973–1977CrossRefPubMed

29.

Kawamoto S, Permpongkosol S, Bluemke DA, Fishman EK, Solomon SB (2007) Sequential changes after radiofrequency ablation and cryoablation of renal neoplasms: role of CT and MR imaging. Radiographics 27:343–355CrossRefPubMed

30.

Smith AD, Shah SN, Rini BI, Lieber ML, Remer EM (2010) Morphology, attenuation, size and structure (MASS) criteria: assessing response and predicting clinical outcome in metastatic renal cell carcinoma on antiangiogenic targeted therapy. Am J Radiol 194:1470–1478

31.

Choyke P, Glenn GM, Walther MM, et al. (1995) von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 194:629–642CrossRefPubMed

32.

Leung R, Biswas SV, Duncan M, Rankin S (2008) Imaging features of von-Hippel-Lindau disease. RadioGraphics 28:65–79CrossRefPubMed

33.

Northrup B, Jokerst CE, Grubb RL, et al. (2012) hereditary renal tumor syndromes: imaging findings and management strategies. Am J Radiol 199(6):1294–1304

34.

Pavlovich CP, Walther MM, Eyler RA, et al. (2002) Renal tumors in the Birt-Hogg-Dube syndrome. Am J Surg Pathol 26:1542–1552CrossRefPubMed

35.

Gupta S, Kang HC, Ganeshan DM, Bathala TK, Kundra V (2015) Diagnostic approach to hereditary renal cell carcinoma. Am J Radiol 204:1031–1041

36.

Smit DL, Mensenkamp AR, Badeloe S, et al. (2011) Hereditary leiomyomatosis and renal cell cancer in families referred for fumarate hydratase germline mutation analysis. Clin Genet 79:49–59CrossRefPubMed

37.

Tsaras G, Owusu-Ansah A, Boaend FO, Amoateng-Adjepong Y (2009) Complications associated with sickle cell trait: a brief narrative review. Am J Med 122:507–512CrossRefPubMed

» This content is intended only for healthcare providers and was made possible by educational funding provided by F. Hoffmann-La Roche Ltd.

Medicine Matters Oncology

Abstract